Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock

Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by Extra Corporeal Membrane Oxygenation Veno-arterial (ECMO VA) for Refractory Cardiogenic Shock

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Brief Summary : Rhythm disorders are a frequent and potentially serious complication of critical patients in the ICU and postoperative cardiac surgery. In particular, atrial fibrillation (AF) is the most common rhythm disorder in patients admitted to the ICU and is associated with excess mortality during acute circulatory failure. In postoperative cardiac surgery, AF affects 15 to 45% of patients. In addition to hemodynamic effects, AF increases the risk of stroke, bleeding, respiratory or renal failure, and doubles mortality at 30 days and 6 months. In the longer term, the recurrence rate of AF within 1 year after hospital discharge is about 50%. Similarly, other rhythm disorders, supraventricular or ventricular, can be life-threatening in ICU patients. While the incidence and complications of rhythm disorders are well documented during sepsis, cardiogenic shock or after cardiac surgery, there are to our knowledge no data on the frequency and complications of rhythm disorders in patients assisted by VA ECMO. The primary objective is to describe the incidence of supraventricular rhythm disorders in patients assisted by VA ECMO.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient 18 years of age or older - Assistance with VA ECMO Who Should NOT Join This Trial: - Opposition to the use of data. - Persons under legal protection (curators, guardianship), judicially safeguarded. - VA ECMO for refractory cardiac arrest. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient 18 years of age or older * Assistance with VA ECMO Exclusion Criteria: * Opposition to the use of data. * Persons under legal protection (curators, guardianship), judicially safeguarded. * VA ECMO for refractory cardiac arrest.

Treatments Being Tested

OTHER

Follow up by phone call

Centralized review of ECGs by the Pitié-Salpêtrière rhythmology department and collection of vital status at 12 months (if information not available, telephone call to the patient)

Locations (20)

CHU Angers
Angers, France
Hospices Civils de Lyon - Hôpital Louis Pradel
Bron, France
CHU Caen Normandie - Hôpital Côte de Nacre
Caen, France
CHRU Tours - Hôpital Trousseau
Chambray-lès-Tours, France
CHU Dijon Bourgogne - Hôpital François Mitterrand
Dijon, France
CHU Grenoble Alpes - Site Nord
Grenoble, France
CHU Lille - Institut Cœur Poumon
Lille, France
CHU Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
CHU Nantes - Hôpital Nord Laennec
Nantes, France
Pitié Salpêtrière Hospital, Intensive Care Unit - Resuscitation
Paris, France
Pitié-Salpêtrière Hospital, Cardiovascular Surgery Intensive Care Unit
Paris, France
Hôpital Européen Georges Pompidou
Paris, France
Hôpital Bichat
Paris, France
Hôpital Bichat
Paris, France
CHU Bordeaux - Hôpital cardiologique, GH Sud Pessac
Pessac, France
CHU Rennes, Hôpital Pontchaillou
Rennes, France
Hôpitaux universitaires de Strasbourg - Hôpital Civil
Strasbourg, France
CHU Toulouse - Hôpital de Rangueil
Toulouse, France
CHU Toulouse - Hôpital de Rangueil
Toulouse, France
CHRU Nancy - Hôpitaux de Brabois
Vandœuvre-lès-Nancy, France